Pertzye DR 16,000 unit capsule UU 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FM2GD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,137
Award facts
- Contract value 100% obligated
- $2,136.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,136.78 delivery order to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye (pancrelipase) on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, while its parent organization is Cencora, Inc. (doing business as AmerisourceBergen). The contract is performed at the contractor's Conshohocken location and represents a standard delivery order under the broader federal pharmaceutical supply chain.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Through this contract vehicle, AmerisourceBergen supplies critical medical products to various federal healthcare systems including the Defense Health Agency, U.S. Coast Guard, and other government medical institutions, demonstrating the company's significant role as a key pharmaceutical distributor within the federal procurement ecosystem.
Quick answers
Who was awarded contract SPE2DR26FM2GD?
SPE2DR26FM2GD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM2GD worth?
The government has obligated $2,137 on SPE2DR26FM2GD.
Is contract SPE2DR26FM2GD an order under another contract?
Yes. SPE2DR26FM2GD is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2GD competed?
The extent of competition for SPE2DR26FM2GD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award